REG - Induction Healthcare - Update on publication of Audited Final Results

Induction HealthcareAnnouncement

24/10/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221024:nRSX7893Da&default-theme=true

RNS Number : 7893D  Induction Healthcare Group PLC   24 October 2022

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Update on publication of Audited Final Results

 

Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that its audited
final results for the year ended 31 March 2022 will now be released on or
before Monday 28 November 2022. This is as a result of staff shortages at the
Company's auditor and following the unexpected bereavement of a family member
of one of the Company's Board.

 

There is no change to the financial performance and, as previously reported on
22 September
(https://www.londonstockexchange.com/news-article/INHC/extension-to-2022-annual-reporting-deadline/15639144)
, results for FY22 are expected to be in-line with guidance.

 

Induction will announce its interim results for the six months ended 30
September 2022 shortly after the publication of the 2022 audited results.

 

During November, the Board expect to issue a trading update on the six-month
period to 30 September 2022.

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

 James Balmain, Chief Executive Officer

 Guy Mitchell, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0)20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        induction@walbrookpr.com
 Alice Woodings                                         Mob: +44 (0)7407 804 654

 

 

 

About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDMZMZGKFKGZZM